MONARCH CAPITAL MANAGEMENT INC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 938759 FORT WAYNE, IN

Position in REGN

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$2,379,428

-$96,883 QoQ

Shares Held

3,816

+19.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#495

of 1,322 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 5% Shared 0% None 95%

Healthcare · as of Jun 30, 2026

MONARCH CAPITAL MANAGEMENT INC holds $2,379,428 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc. This page	3,816	$2,379,428

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,379,428	3,816	+19.1%	Shares	Sole	2026-07-22
2026-03-31	$2,476,311	3,205	+2.8%	Shares	Sole	2026-04-16
2025-12-31	$2,407,462	3,119	+7.0%	Shares	Sole	2026-01-23
2025-09-30	$1,639,017	2,915	+24.3%	Shares	Sole	2025-10-20
2025-06-30	$1,231,125	2,345	+67.0%	Shares	Sole	2025-08-20
2025-03-31	$890,458	1,404	+31.6%	Shares	Sole	2025-04-15
2024-12-31	$760,056	1,067	+106.0%	Shares	Sole	2025-01-15
2024-09-30	$544,542	518	-8.2%	Shares	Sole	2024-10-16
2024-06-30	$592,780	564	-3.4%	Shares	Sole	2024-07-24
2024-03-31	$562,094	584	0.0%	Shares	Sole	2024-04-25
2023-12-31	$512,921	584	-4.7%	Shares	Sole	2024-01-17
2023-09-30	$504,474	613	-3.2%	Shares	Sole	2023-11-02
2023-06-30	$454,835	633	-2.3%	Shares	Sole	2023-08-01
2023-03-31	$532,442	648	0.0%	Shares	Sole	2023-04-25
2022-12-31	$467,525	648	-0.5%	Shares	Sole	2023-01-26
2022-09-30	$448,454	651	-4.8%	Shares	Sole	2022-10-20
2022-06-30	$404,332	684	-0.7%	Shares	Sole	2022-07-20
2022-03-31	$481,211	689	+43.8%	Shares	Sole	2022-04-20
2021-12-31	$302,498	479	—	Shares	Sole	2022-01-19
No filing history on record for this holder in this stock.